Prevalence of primary immune thrombocytopenia in Oklahoma

被引:69
|
作者
Terrell, Deirdra R. [1 ]
Beebe, Laura A. [1 ]
Neas, Barbara R. [1 ]
Vesely, Sara K. [1 ]
Segal, Jodi B. [2 ]
George, James N. [1 ,3 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73126 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Med, Oklahoma City, OK 73126 USA
关键词
QUALITY-OF-LIFE; PURPURA; ADULTS; CHILDHOOD; CHILDREN; PATIENT;
D O I
10.1002/ajh.23262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the prevalence of immune thrombocytopenia (ITP) in Oklahoma regardless of age, clinical characteristics, insurance status, and source of health care. Patients with ITP were identified by the administrative code ICD-9-CM 287.3 in Oklahoma hematologists' offices for a 2-year period, 20032004. Prevalence was estimated separately for children (<16 years old) and adults because of their distinct clinical characteristics. Oklahoma census data for 2000 was used as the denominator. Eighty-seven (94%) of 93 eligible Oklahoma hematologists participated; 620 patients with ITP were identified. The average annual prevalences were as follows: 8.1 (95% CI: 6.79.5) per 100,000 children, 12.1 (95% CI: 11.113.0) per 100,000 adults, and 11.2 (95% CI: 10.412.0) per 100,000 population. Among children and adults less than age 70 years, the prevalence was greater among women. Among adults aged 70 years and older, the prevalence was greater among men. The highest prevalence of ITP was among men age 80 years and older. These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care. The methodology developed for this prevalence analysis may be adaptable for epidemiologic studies of other uncommon disorders which lack specific diagnostic criteria and are treated primarily by medical specialists. Am. J. Hematol. 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:848 / 852
页数:5
相关论文
共 50 条
  • [1] Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists
    Lu, Kaelyn H.
    George, James N.
    Vesely, Sara K.
    Terrell, Deirdra R.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (03): : 190 - 194
  • [2] Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists
    Lu, Kaelyn H.
    George, James N.
    Vesely, Sara K.
    Terrell, Deirdra R.
    BLOOD, 2012, 120 (21)
  • [3] Prevalence of anti-glycoprotein V in patients with primary immune thrombocytopenia
    Azzazi, Mohamed O.
    Nabeeh, Nermeen A.
    Mohamed, Asmaa M.
    Abdelfatah, Rana G.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (01): : 29 - 35
  • [4] Primary Immune Thrombocytopenia in Pregnancy
    Tran, Bryant W.
    May, Keith A.
    Pal, Nirvik
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (18): : 1728 - 1728
  • [5] Pathophysiology of primary immune thrombocytopenia
    Stasi, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 251 - 251
  • [6] Immune dysregulation in primary immune thrombocytopenia patients
    Zhang, Jiakui
    Zhang, Qiuye
    Li, Yingwei
    Tao, Lili
    Wu, Fan
    Shen, Yuanyuan
    Tao, Qianshan
    Xu, Xuanxuan
    Wu, Can
    Ruan, Yanjie
    Wang, Jiyu
    Wang, Jeffrey
    Wang, Yiping
    Zhai, Zhimin
    HEMATOLOGY, 2018, 23 (08) : 510 - 516
  • [7] Management of Primary Immune Thrombocytopenia in Pregnancy
    Bussel, James B.
    Hou, Ming
    Cines, Douglas B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (06): : 540 - 548
  • [8] New treatments for primary immune thrombocytopenia
    Mingot-Castellano, Maria Eva
    BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 : S8 - S11
  • [9] Pathophysiology and management of primary immune thrombocytopenia
    Kashiwagi, Hirokazu
    Tomiyama, Yoshiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (01) : 24 - 33
  • [10] Markers of refractory primary immune thrombocytopenia
    Moulis, Guillaume
    Garabet, Lamya
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (01) : 112 - 118